Massachusetts Financial Services
MGNX icon

Massachusetts Financial Services’s MacroGenics MGNX Stock Holding History

Massachusetts Financial Services’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,754
Closed -$134K – 905
2024
Q3 		$134K Sell
40,754
-988
-2% -$3.85K ﹤0.01% 842
2024
Q2 		$177K Buy
41,742
+1,402
+3% +$13.7K ﹤0.01% 854
2024
Q1 		$594K Sell
40,340
-124,767
-76% -$1.89M ﹤0.01% 807
2023
Q4 		$1.59M Sell
165,107
-29,097
-15% -$201K ﹤0.01% 741
2023
Q3 		$905K Buy
194,204
+48,118
+33% +$240K ﹤0.01% 773
2023
Q2 		$782K Sell
146,086
-3,442
-2% -$21.2K ﹤0.01% 769
2023
Q1 		$1.07M Buy
149,528
+50,931
+52% +$307K ﹤0.01% 755
2022
Q4 		$662K Buy
98,597
+2,086
+2% +$11.4K ﹤0.01% 803
2022
Q3 		$334K Sell
96,511
-880
-0.9% -$3.37K ﹤0.01% 826
2022
Q2 		$287K Buy
97,391
+493
+0.5% +$2.59K ﹤0.01% 835
2022
Q1 		$854K Buy
96,898
+18,599
+24% +$205K ﹤0.01% 801
2021
Q4 		$1.26M Buy
78,299
+39,894
+104% +$751K ﹤0.01% 806
2021
Q3 		$804K Sell
38,405
-42,079
-52% -$1.01M ﹤0.01% 848
2021
Q2 		$2.16M Sell
80,484
-20,379
-20% -$597K ﹤0.01% 772
2021
Q1 		$3.21M Sell
100,863
-11,955
-11% -$290K ﹤0.01% 722
2020
Q4 		$2.58M Sell
112,818
-1,132
-1% -$26.1K ﹤0.01% 710
2020
Q3 		$2.87M Sell
113,950
-36,220
-24% -$989K ﹤0.01% 690
2020
Q2 		$4.19M Sell
150,170
-3,826
-2% -$66.5K ﹤0.01% 645
2020
Q1 		$896K Buy
153,996
+24,375
+19% +$221K ﹤0.01% 742
2019
Q4 		$1.41M Sell
129,621
-14,011
-10% -$139K ﹤0.01% 744
2019
Q3 		$1.83M Buy
143,632
+68,059
+90% +$980K ﹤0.01% 731
2019
Q2 		$1.28M Buy
75,573
+10,527
+16% +$181K ﹤0.01% 772
2019
Q1 		$1.17M Sell
65,046
-30,769
-32% -$532K ﹤0.01% 770
2018
Q4 		$1.22M Buy
95,815
+39,605
+70% +$664K ﹤0.01% 757
2018
Q3 		$1.21M Sell
56,210
-131
-0.2% -$2.79K ﹤0.01% 773
2018
Q2 		$1.16M Buy
+56,341
New +$1.27M ﹤0.01% 767
2015
Q4 		– Sell
-13,603
Closed -$291K – 866
2015
Q3 		$291K Sell
13,603
-2,952
-18% -$92.6K ﹤0.01% 846
2015
Q2 		$629K Buy
+16,555
New +$544K ﹤0.01% 817

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Massachusetts Financial Services's MGNX Position: Q4 2024 in Review

Massachusetts Financial Services sold out of MacroGenics (MGNX) in Q4 2024, closing a stake of 40,754 shares — an estimated $134K sold.

Massachusetts Financial Services first reported a position in MGNX in Q2 2015 and held it in 28 quarters. The position peaked at $4.19M in Q2 2020. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2024.

  • Massachusetts Financial Services reported no remaining MacroGenics position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 40,754 MacroGenics shares in Q4 2024, an estimated $134K.
  • Massachusetts Financial Services first reported a position in MacroGenics in Q2 2015 and held it in 28 quarters.
  • Massachusetts Financial Services's MacroGenics position peaked at $4.19M in Q2 2020.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.